Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3dd802bf7a53f5320961a7f060aa02a |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate |
1995-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8cf1a7b37ff00c082eac434f13b9e6c |
publicationDate |
1996-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H08245698-A |
titleOfInvention |
Human type 1 inositol trisphosphate receptor |
abstract |
(57) [Summary] [Objective] It is an object to provide a human type 1 inositol trisphosphate receptor and its use. [Structure] The human type 1 inositol trisphosphate receptor of the present invention is a protein having a specific amino acid sequence and capable of binding to inositol trisphosphate (IP3). Since the human type 1 inositol trisphosphate receptor of the present invention can bind to IP3, the action of IP3 It is useful as a reagent for studying the mechanism and as a calcium release inhibitor. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11618790-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11407836-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6465211-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016500511-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10106612-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9862779-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11421022-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7041440-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0992587-A3 |
priorityDate |
1995-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |